Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal lumen toxins represent a broad category of pathogenic molecules produced by bacteria, fungi, or ingested from the environment that exert deleterious effects within the digestive tract. This group includes potent bacterial exotoxins such as Clostridioides difficile toxins A and B, Shiga toxins, and cholera toxin, as well as cell wall components like lipopolysaccharides (endotoxins). These toxins typically function by disrupting the intestinal epithelial barrier, altering intracellular signaling (e.g., via ADP-ribosylation or Rho GTPase inactivation), and inducing massive fluid secretion or inflammatory responses. In clinical practice, these toxins are the primary drivers of severe diarrheal diseases, colitis, and systemic inflammatory syndromes. Therapeutic strategies targeting these toxins involve the use of oral adsorbents to sequester the molecules within the lumen or systemic monoclonal antibodies to neutralize their biological activity before they can damage host tissues. Because this term encompasses a wide variety of chemically distinct molecules rather than a single protein or receptor, it is generally considered a therapeutic category rather than a specific molecular target.
Neutralization of toxin activity via monoclonal antibody binding; physical adsorption and sequestration by non-absorbable polymers or charcoal to prevent systemic absorption or local mucosal damage.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal lumen toxins (GI lumen toxins).